- £359.66m
- £963.36m
- $1.12bn
Annual income statement for Enquest, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,266 | 1,854 | 1,487 | 1,181 | 1,118 |
| Cost of Revenue | |||||
| Gross Profit | 366 | 653 | 541 | 393 | 281 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 686 | 1,476 | 1,090 | 866 | 470 |
| Operating Profit | 580 | 378 | 397 | 315 | 649 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 352 | 203 | 232 | 167 | 493 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 377 | 185 | 85.6 | 115 | 221 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 377 | -41.2 | -30.8 | 93.8 | 1.56 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 377 | -41.2 | -30.8 | 93.8 | 1.56 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.229 | 0.303 | 0.148 | 0.134 | -0.07 |
| Dividends per Share |